Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
allergan
4
×
biotech
clinical trials
fda
life sciences
national
4
×
national blog main
national top stories
new york blog main
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
europe blog main
indiana blog main
indiana top stories
ipo
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
astrazeneca
biogen
boston top stories
cancer
crispr
europe top stories
What
bio
roundup
fda
medicines
acquisitions
adults
allergan
announced
approved
august
biotech
black
busy
ceo
class
collabs
companies
continue
covid
daniel
days
deal
debut
decisions
devices
diamond
diamond’s
drugs
gilead
gilead’s
help
indication
introduce
ipo
leading
legacy
life
mammoth
march
migraine
Language
unset
Current search:
allergan
×
national
×
abbvie
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More